Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial

This open-label, single-center, Phase 3 study (NCT03546842) assessed the immunogenicity and safety of the nine-valent human papillomavirus (9vHPV; HPV6/11/16/18/31/33/45/52/58) vaccine in Vietnamese males and females, with the aim to support 9vHPV vaccine licensure in Vietnam. Participants aged 9–26...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiem, Vu Dinh, Quang, Nguyen Dang, Tuan, Nguyen Hai, Cheon, Kyeongmi, Gallagher, Nancy, Luxembourg, Alain, Group, Thomas, Badshah, Cyrus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189095/
https://www.ncbi.nlm.nih.gov/pubmed/33844623
http://dx.doi.org/10.1080/21645515.2020.1865739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189095/
https://www.ncbi.nlm.nih.gov/pubmed/33844623
http://dx.doi.org/10.1080/21645515.2020.1865739

Ejemplares similares